Melanoma and other skin tumours

Date 01 October 2019
Event ESMO 2019 Congress
Session Congress Highlights 2 - The best of ESMO 2019
Topics Skin Cancers
Non-Melanoma Skin Cancers
Presenter Piotr Rutkowski
Authors P. Rutkowski
  • The Maria Sklodowska Curie Memorial Cancer Centre and Institute of Oncology (MCMCC), 02-781 - Warsaw/PL

LBA68_PR: 5-year survival outcomes of the CheckMate 067 phase 3 trial of nivolumab plus ipilimumab (NIVO+IPI) combination therapy in advanced melanoma, by James Larkin

LBA67: Adjuvant immunotherapy with nivolumab (NIVO) alone or in combination with ipilimumab (IPI) versus placebo in stage IV melanoma patients with no evidence of disease (NED): A randomized, double-blind phase 2 trial (IMMUNED), by Dirk Schadendorf